title: [Treatment of tobacco dependence: a responsibility of psychiatry and addiction medicine].
abstract: The World Health Organisation (WHO) considers smoking to be the biggest avoidable health risk. The consumption of tobacco leads to health hazards and resulting diseases, the consequences of which are far more serious than those emanating from other addictive substances. Approximately 27% of the German adult population smoke regularly and the proportion of smokers addicted to tobacco or nicotine is estimated to be around 60%. Many of these smokers have undertaken numerous unsuccessful attempts at abstinence. A professional support for smokers who are motivated to give up smoking enhances the chances of success. The current treatment guidelines recommend a combination of psychotherapeutic techniques (e.g. motivational interviewing, behavioural therapy-oriented support either individually or in groups) together with pharmacological support (e.g. nicotine replacement therapy, bupropion or varenicline). Certain subgroups (e.g. pregnant smokers, juvenile smokers and, in particular, smokers with a psychiatric co-morbidity) require a more intense psychotherapy and when necessary pharmacotherapeutic support.
authors.affiliation: Sektion Suchtforschung und Suchtmedizin, Universitätsklinik für Psychiatrie und Psychotherapie, Osianderstrasse 24, 72076, Tübingen, Deutschland. anil.batra@med.uni-tuebingen.de
authors.forename: A
authors.initials: A
authors.lastname: Batra
authors.forename: H M
authors.initials: HM
authors.lastname: Friederich
authors.forename: U
authors.initials: U
authors.lastname: Lutz
mesh_terms: D003131:Combined Modality Therapy; D005858:Germany / Q000453:epidemiology; D006801:Humans; D009538:Nicotine / Q000627:therapeutic use*; D011570:Psychiatry / Q000639:trends; D011613:Psychotherapy / Q000639:trends*; D012907:Smoking / Q000453:epidemiology / Q000523:psychology*; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology*; D000074606:Smoking Prevention; D014029:Tobacco Use Disorder / Q000453:epidemiology / Q000517:prevention & control* / Q000523:psychology*
chemical_list: D009538:Nicotine
references.citation: Tob Control. 2006 Dec;15(6):464-71
references.pmid: 17130376
references.citation: Z Arztl Fortbild Qualitatssich. 2002 Jun;96(5):281-6
references.pmid: 12168547
references.citation: Nicotine Tob Res. 2007 Mar;9(3):315-27
references.pmid: 17365764
references.citation: Cochrane Database Syst Rev. 2000;(2):CD001008
references.pmid: 10796583
references.citation: Addiction. 2004 Dec;99(12):1586-98
references.pmid: 15585050
references.citation: Gen Hosp Psychiatry. 2009 Mar-Apr;31(2):131-6
references.pmid: 19269533
references.citation: Addiction. 2009 May;104(5):859-61
references.pmid: 19413797
references.citation: Cochrane Database Syst Rev. 2004;(3):CD000146
references.pmid: 15266423
references.citation: Br J Addict. 1991 Sep;86(9):1119-27
references.pmid: 1932883
references.citation: J Subst Abuse Treat. 2008 Jul;35(1):41-52
references.pmid: 17931825
references.citation: Addiction. 2000 Jan;95 Suppl 1:S3-7
references.pmid: 10723815
references.citation: Tob Control. 2007 Feb;16(1):15-21
references.pmid: 17297068
references.citation: Pneumologie. 2008 May;62(5):255-72
references.pmid: 18461537
references.citation: Fortschr Neurol Psychiatr. 2000 Feb;68(2):80-92
references.pmid: 10719661
references.citation: Arch Intern Med. 2009 Feb 9;169(3):230-5; discussion 235-6
references.pmid: 19204212
references.citation: Am J Health Promot. 1997 Sep-Oct;12(1):38-48
references.pmid: 10170434
references.citation: Addiction. 2008 Jan;103(1):146-54
references.pmid: 18028247
references.citation: Gesundheitswesen. 2001 Jun;63(6):363-9
references.pmid: 11467218